Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).
about
The European Hematology Association Roadmap for European Hematology Research: a consensus documentInvasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality?High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan.Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country.How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.The risk of infections in patients with myelodysplastic syndromes in 2016.Hyperglycemia as a possible risk factor for mold infections-the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation.Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infection.Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report.Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia.Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.How I treat acute myeloid leukemia presenting with preexisting comorbidities.Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAG.A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia.Factors Associated to Invasive Fungal Infection in Hispanic Patients with Hematological Malignancies.
P2860
Q28830861-380D8E58-59AC-44B8-A15E-AC1EC37ABAAFQ30240242-EC729D8F-F7C5-4D77-BBDD-366B6F2DA9C3Q35659664-8E792191-DADA-487D-A15C-84FE53E4E832Q38665409-28ECF12A-7552-4B25-90EA-82F53D5880ECQ38797551-25FFBDA4-B28B-4A6C-BE9A-1D353FA1C3A8Q38813702-5CB2EF60-19C8-4676-9EDD-337FA6B620B1Q39035934-EC09997F-F880-4B1C-A2C9-F452811E7ACBQ40067975-98E78041-19FB-4BAD-858B-D80C680EED0CQ40125779-FAFDCA13-B937-4ABB-ACF3-21EB2173119CQ40254512-C00DEFDA-5BCE-4900-9CF2-D7931C86DAA6Q40515140-3DBC0E5F-F9E5-49D9-B873-A8A6458DB37CQ41107043-1D938190-D1FB-4920-A8D7-790F990189AAQ47232101-C25932BB-898B-45FB-AF4F-CF1D44BFD392Q49151914-8868F37E-9056-45E6-9A1E-77888741B454Q55121434-3AC69ABD-92EE-487E-A936-C9F66CF404BC
P2860
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pre-chemotherapy risk factors ...... FEM 2010-a multicenter study).
@ast
Pre-chemotherapy risk factors ...... FEM 2010-a multicenter study).
@en
type
label
Pre-chemotherapy risk factors ...... FEM 2010-a multicenter study).
@ast
Pre-chemotherapy risk factors ...... FEM 2010-a multicenter study).
@en
prefLabel
Pre-chemotherapy risk factors ...... FEM 2010-a multicenter study).
@ast
Pre-chemotherapy risk factors ...... FEM 2010-a multicenter study).
@en
P2093
P2860
P50
P1433
P1476
Pre-chemotherapy risk factors ...... FEM 2010-a multicenter study).
@en
P2093
Adriana Vacca
Anna Candoni
Anna Chierichini
Annamaria Nosari
Annunziata Manna
Antonella Ferrari
Antonio Spadea
Carlo Castagnola
Cecilia Caramatti
Chiara Cattaneo
P2860
P304
P356
10.3324/HAEMATOL.2014.113399
P50
P577
2015-02-01T00:00:00Z